FDA Clearance Tracker · P160043-S034
Resolute Onyx Zotarolimus-Eluting Coronary Stent System
Last checked: Nov 20, 2026Latest source record: Sep 22, 2020 (this decision)Source: openFDAMethods & limitations
Decided
Sep 22, 2020
Approved
Time to decision
179 days
Received Mar 27, 2020. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Panel Track
Device class
Class III
The decision
- FDA number
- P160043-S034
- Device name
- Resolute Onyx Zotarolimus-Eluting Coronary Stent System
- Applicant
- Medtronic Vascular
- Applicant location
- Santa Rosa, CA
- Received
- Mar 27, 2020
- Decided
- Sep 22, 2020
- Decision
- Approved
- Supplement type
- Panel Track
- Reason for supplement
- Labeling Change - Indications/instructions/shelf life/tradename
- Original approval
- P160043
Device type
- Device type
- Coronary drug-eluting stent (NIQ)
- Device class
- Class III
- Specialty
- CardiologyInterventional Cardiology
FDA's approval statement
As written in FDA's record.
Approval for expanding the labeling to include patients at high risk for bleeding. This device is indicated as follows: The Resolute Onyx Zotarolimus-Eluting Coronary Stent System is indicated for improving coronary luminal diameters in patients, including those with diabetes mellitus or high bleeding risk, with symptomatic ischemic heart disease due to de novo lesions of length <= 35 mm in native coronary arteries with reference vessel diameters of 2.0 mm to 5.0 mm. In addition, the Resolute Onyx Zotarolimus-Eluting Coronary Stent System is indicated for treating de novo chronic total occlusions.
Source documents
Other decisions for Medtronic Vascular
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K232570 · Decided Oct 24, 2023 · 61 days after receipt
Device type: Wire, Guide, Catheter (DQX) · Cardiology
K232190 · Decided Aug 22, 2023 · 29 days after receipt
Device type: Catheter, Percutaneous (DQY) · Cardiology
K230156 · Decided Jun 30, 2023 · 162 days after receipt
Device type: Catheter, Percutaneous (DQY) · Cardiology
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.